These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 1412208

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio.
    Kario K, Matsuo T, Kodama K, Matsuo M, Yamamoto K, Kobayashi H.
    Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720
    [Abstract] [Full Text] [Related]

  • 3. Plasma levels of heparin cofactor II (HCII) and thrombin-HCII complex in patients with disseminated intravascular coagulation.
    Noda A, Wada H, Kusiya F, Sakakura M, Onishi K, Nakatani K, Gabazza EC, Asahara N, Tsukada M, Nobori T, Shiku H.
    Clin Appl Thromb Hemost; 2002 Jul; 8(3):265-71. PubMed ID: 12361205
    [Abstract] [Full Text] [Related]

  • 4. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K, Takaki A, Takeda S, Katoh H, Ohsato K.
    Haemostasis; 1992 Jul; 22(1):17-24. PubMed ID: 1387863
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elevated levels of thrombin-heparin cofactor II complex in plasma from patients with disseminated intravascular coagulation.
    Andersson TR, Sie P, Pelzer H, Aamodt LM, Nustad K, Abildgaard U.
    Thromb Res; 1992 Jun 01; 66(5):591-8. PubMed ID: 1523613
    [Abstract] [Full Text] [Related]

  • 8. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders.
    Takahashi H, Tatewaki W, Wada K, Hanano M, Shibata A.
    Am J Hematol; 1990 Feb 01; 33(2):90-5. PubMed ID: 1689102
    [Abstract] [Full Text] [Related]

  • 9. Heparin cofactor II deficiency in the elderly: comparison with antithrombin III.
    Kario K, Matsuo T, Kobayashi H.
    Thromb Res; 1992 Jun 01; 66(5):489-98. PubMed ID: 1381849
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
    Shahmarvand N, Oak JS, Cascio MJ, Alcasid M, Goodman E, Medeiros BC, Arber DA, Zehnder JL, Ohgami RS.
    Int J Lab Hematol; 2017 Aug 01; 39(4):375-383. PubMed ID: 28422420
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ, Nieuwenhuis HK, Bos R, Fijnheer R.
    Thromb Haemost; 2000 Jun 01; 83(6):906-8. PubMed ID: 10896247
    [Abstract] [Full Text] [Related]

  • 15. Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation.
    Gando S, Nanzaki S, Sasaki S, Kemmotsu O.
    Thromb Haemost; 1998 Jun 01; 79(6):1111-5. PubMed ID: 9657433
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antithrombin III and anti-activated factor X activity in patients with acute promyelocytic leukemia and disseminated intravascular coagulation treated with heparin.
    Sandler RM, Liebman HA, Patch MJ, Teitelbaum A, Levine AM, Feinstein DI.
    Cancer; 1983 Feb 15; 51(4):681-5. PubMed ID: 6571800
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H, Zhu CY, Wang QS, Niu JH, Zhang Q, Zhu HY, Yao ZL, Xu YY, Jing Y, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr 15; 22(2):315-22. PubMed ID: 24762998
    [Abstract] [Full Text] [Related]

  • 20. Activity and antigen levels of thrombin-activatable fibrinolysis inhibitor in plasma of patients with disseminated intravascular coagulation.
    Watanabe R, Wada H, Watanabe Y, Sakakura M, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Nobori T, Shiku H.
    Thromb Res; 2001 Oct 01; 104(1):1-6. PubMed ID: 11583733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.